Clin2
NCT05860699Possibly a fitRecruiting

Cannabidiol added during inpatient alcohol withdrawal

Severe Alcohol Use Disorder (DSM 5)

Part of Mental health clinical trials.

This trial tests whether cannabidiol (CBD) given during an inpatient alcohol detox helps people stay off alcohol afterward. You would be compared with standard care to see if CBD improves recovery during and after withdrawal.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
210 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18–75 years old
  • You are currently hospitalized for a planned alcohol detox (inpatient withdrawal)
  • You meet criteria for severe alcohol use disorder and agree to join
  • You can attend follow-up visits after you leave the hospital
  • If you can become pregnant, you must use effective birth control during the study and for 7 days after CBD
  • You must be able to take the study medicine safely with your current health and medicines

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07148843Not yet recruiting· Phase 2/Phase 3
CBD for Alcohol Withdrawal and Cravings

This study tests whether cannabidiol (CBD) can help reduce alcohol withdrawal symptoms and cravings when added to usual care. If you are a heavy drinker with alcohol use disorder and have experienced withdrawal, this trial may offer a new approach to manage cravings and safely quit drinking.

Baltimore, Maryland
NCT05613608Recruiting· Phase 2/Phase 3
Cannabidiol (CBD) study for alcohol use disorder

This trial tests whether cannabidiol (CBD) can help people cut down or quit drinking alcohol. It enrolls adults diagnosed with alcohol use disorder and wanting to reduce drinking, while checking for safety and other mental health or drug use factors.

Aurora, Colorado
NCT06512389Recruiting· Phase 2
Testing CBD for alcohol cravings

This study tests whether a medication called cannabidiol (CBD) can help reduce cravings for alcohol. Over several weeks, you will take the study pill and attend lab sessions where you can choose to drink alcohol in a safe setting.

Toronto, Ontario
NCT07527338Not yet recruiting· Phase 2
Cannabidiol for sleep and alcohol use support

This study tests whether cannabidiol (CBD), a non-intoxicating compound from cannabis, can improve sleep quality in people who drink alcohol at risky levels. Researchers want to understand how CBD works and whether it could help people sleep better while reducing harmful drinking.

NCT07279558Recruiting· Phase 2
CBD and Alcohol Use Study

This study tests whether cannabidiol (CBD), a compound from cannabis, can help people who drink alcohol regularly reduce their drinking or change their drinking patterns. You may be eligible if you're 21-65, have used CBD or cannabis before, drink alcohol regularly, and don't take certain medications that could interfere.

Aurora, Colorado
NCT06845124Recruiting· Phase 2
Testing CBD and naltrexone for alcohol craving

This trial is testing if taking cannabidiol (CBD) plus naltrexone can reduce alcohol craving in people with alcohol dependence. Naltrexone is already used to help with alcohol cravings, and CBD may add extra benefit.

Wiesloch, Baden-Wurttemberg

Hear when a new Severe Alcohol Use Disorder (DSM 5) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.